Bosulif Tablet, Film Coated
Product Images NDC 0069-0135

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bosulif (NDC 0069-0135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bosulif 01)

Chemical structure of Bosutinib, the active ingredient in BOSULIF tablets. The diagram shows the molecular arrangement including rings, chlorine atoms, methoxy groups, and a hydrate component (H2O).*

FDA Label Image

Logo (Bosulif 02)

FDA Label Image

Logo (Bosulif 03)

FDA Label Image

Principal Display Panel (100 mg Bottle Label)

Label for Bosulif (bosutinib) tablets 100 mg by Pfizer Laboratories Division of Pfizer Inc. The oral film-coated tablet packaging states 120 tablets per container and is for oncology use only. Storage instructions specify 20°C to 25°C with permitted excursions between 15°C and 30°C. The label includes warnings not to crush or cut tablets and indicates prescription-only status.*

FDA Label Image

Principal Display Panel (500 mg Bottle Label)

Bosulif (bosutinib) 500 mg film-coated tablets label from Pfizer Laboratories, an oral oncology prescription drug. The label indicates storage conditions, cautions not to crush or cut tablets, and states the package contains 30 tablets. It includes NDC 0069-0136-01 and manufacturing details showing distribution by Pfizer Labs in New York and made in Spain.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Bosulif (bosutinib) tablets 400 mg film-coated oral tablets label. Contains 30 tablets per package. Distributed by Pfizer Laboratories Division of Pfizer Inc. Instructions include storage at 20° to 25°C, use in child-resistant containers, and a caution not to crush or cut tablets. Labeled for oncology use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.